Calliditas Therapeutics AB (FRA:LC8) Total Tax Payable : €0.55 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Calliditas Therapeutics AB Total Tax Payable?

Calliditas Therapeutics AB's Total Tax Payable for the quarter that ended in Dec. 2023 was €0.55 Mil.

Calliditas Therapeutics AB's quarterly Total Tax Payable stayed the same from Jun. 2023 (€0.00 Mil) to Sep. 2023 (€0.00 Mil) but then increased from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€0.55 Mil).

Calliditas Therapeutics AB's annual Total Tax Payable increased from Dec. 2021 (€0.12 Mil) to Dec. 2022 (€0.52 Mil) and increased from Dec. 2022 (€0.52 Mil) to Dec. 2023 (€0.55 Mil).

Calliditas Therapeutics AB Total Tax Payable Historical Data

The historical data trend for Calliditas Therapeutics AB's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calliditas Therapeutics AB Total Tax Payable Chart

Calliditas Therapeutics AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

0.01

0.05

0.12

0.52

0.55

Calliditas Therapeutics AB Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Total Tax Payable	Get a 7-Day Free Trial															-	0.52	-	-	0.55

Calliditas Therapeutics AB Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Calliditas Therapeutics AB Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Calliditas Therapeutics AB's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Calliditas Therapeutics AB (FRA:LC8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calliditas Therapeutics AB (FRA:LC8) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

CALT:USA CALTX:Sweden CALTXs:UK

Address

Kungsbron 1, D5, Stockholm, SWE, SE-111 22

Website

https://www.calliditas.se

Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.

Calliditas Therapeutics AB (FRA:LC8) Headlines

No Headlines